Subacute Cutaneous Lupus Erythematosus Exacerbated or Induced by Chemotherapy

被引:0
|
作者
Funke, Alisa A. [1 ]
Kulp-Shorten, Carol L. [1 ]
Callen, Jeffrey P. [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Med, Div Dermatol, Louisville, KY 40292 USA
关键词
CAPECITABINE; SUBSET;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Subacute cutaneous lupus erythematosus (SCLE), characterized by nonscarring, photodistributed, annular or papulosquamous plaques, is occasionally induced by medication. It has been strongly associated with antihypertensive medications and terbinafine hydrochloride. Observation: We describe 3 women with breast cancer who developed SCLE-like eruptions after being administered doxorubicin hydrochloride and cyclophosphamide. Biopsy specimens of all 3 patients demonstrated an interface dermatitis. Treatment consisted of topical and/or systemic corticosteroids, photoprotection, and switching the chemotherapeutic regimens. Conclusions: Based on clinicopathologic correlation and timing of chemotherapy exposure, the patients were believed to have drug-induced SCLE. Although cutaneous eruption, pruritus, and photosensitivity are known adverse effects of doxorubicin, to our knowledge there has been only 1 previously reported case of doxorubicin-induced SCLE.
引用
收藏
页码:1113 / 1116
页数:4
相关论文
共 50 条
  • [11] Capecitabine-induced subacute cutaneous lupus: A case report
    Fongue, J.
    Meunier, B.
    Lardet, D.
    Dicostanzo, M. -P.
    Rouby, F.
    Terrier, J. -P.
    Harle, J. -R.
    Richard, M. -A.
    Chiche, L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (10): : 593 - 597
  • [12] Chronic cutaneous lupus erythematosus induced by 5-fluorouracil
    Cohen, Philip R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (08) : 917 - 918
  • [13] Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation
    Sontheimer, Richard D.
    Henderson, Clifford L.
    Grau, Renee H.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 65 - 70
  • [14] Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE)
    Tiao, Janice
    Feng, Rui
    Carr, Kasey
    Okawa, Joyce
    Werth, Victoria P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : 862 - 869
  • [16] Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus
    Furukawa, Fukumi
    Muto, Masahiko
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 111 - 115
  • [17] Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden
    Gronhagen, C. M.
    Fored, C. M.
    Linder, M.
    Granath, F.
    Nyberg, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) : 296 - 305
  • [18] The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus
    Kuhn, A.
    Patsinakidis, N.
    Bonsmann, G.
    LUPUS, 2010, 19 (09) : 1144 - 1152
  • [19] Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus
    Gronhagen, C. M.
    Gunnarsson, I.
    Svenungsson, E.
    Nyberg, F.
    LUPUS, 2010, 19 (10) : 1187 - 1194
  • [20] Capcetabine-Induced Discoid Cutaneous Lupus
    Moreiras Arias, N.
    Roson Lopez, M. E.
    Suarez Penaranda, J. M.
    Vazquez Veiga, H. A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (09): : 859 - 862